Kaat Kehoe

The Dipeptidyl Peptidase Family, Prolyl Oligopeptidase, and Prolyl Carboxypeptidase in the Immune System and Inflammatory Disease, Including Atherosclerosis

A. Lambeir, I. De Meester, L. Baerts, 2015, Front. Immunol..

Prolyl carboxypeptidase purified from human placenta: its characterization and identification as an apelin-cleaving enzyme.

A. Lambeir, I. De Meester, R. Van Elzen, 2016, Biochimica et biophysica acta.

Dysregulation of the renin-angiotensin system during lung ischemia-reperfusion injury

P. V. Van Schil, A. Lambeir, I. De Meester, 2016, Experimental lung research.

Dysregulated activities of proline-specific enzymes in septic shock patients (sepsis-2)

P. Jorens, A. Lambeir, I. De Meester, 2020, PloS one.

Validation of a specific prolylcarboxypeptidase activity assay and its suitability for plasma and serum measurements.

A. Lambeir, I. De Meester, P. Van der Veken, 2013, Analytical biochemistry.

Nationwide Harmonization Effort for Semi-Quantitative Reporting of SARS-CoV-2 PCR Test Results in Belgium

P. Maes, B. Bearzatto, E. André, 2022, Viruses.

Acute Ischemic Stroke Severity, Progression, and Outcome Relate to Changes in Dipeptidyl Peptidase IV and Fibroblast Activation Protein Activity

S. Engelborghs, I. De Meester, R. Brouns, 2016, Translational Stroke Research.

Acute ischemic stroke severity , progression and outcome relates to changes in dipeptidyl peptidase IV and fibroblast activation protein activity Reference

Sebastiaan, Brouns, P. Deyn, 2016 .